NDC 0591-3176 - Citalopram Hydrobromide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-3176
- Package NDCs from labels
- 0591-3176-01, 0591-3176-05
- Manufacturer
- Watson Laboratories, Inc
- Effective date
- 2008-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Citalopram Hydrobromide - Watson Laboratories, Inc | Watson Laboratories, Inc | 2008-01-17 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-3176-01 | Citalopram Hydrobromide | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 0591-3176-05 | Citalopram Hydrobromide | 500 in 1 BOTTLE | TABLET | 500 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Citalopram | CITALOPRAM HYDROBROMIDE | QUALLENT PHARMACEUTICALS HEALTH LLC | e0822069-9672-4d4c-bc1a-8739b0dd045c | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | 283672 200371 309314 |
| Citalopram | CITALOPRAM | Mylan Pharmaceuticals Inc. | 825c0c49-5fbf-6d8b-cb8c-94ebf0eda043 | 2024-06-23 | Boxed warning, Warnings, Adverse reactions | 283672 200371 309314 |
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | NuCare Pharmaceuticals,Inc. | 9987a273-e6d7-54cd-e053-2a95a90a0aaa | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 200371 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Aurobindo Pharma Limited | 2632b547-2e13-447f-ac85-c774e437d6a8 | 2024-05-17 | Boxed warning, Warnings, Adverse reactions | 283672 200371 309314 |
| Citalopram | CITALOPRAM | A-S Medication Solutions | c91684c7-fddb-4cf0-9711-b0484c8c7e8b | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | 200371 |
| Citalopram | CITALOPRAM | A-S Medication Solutions | 17af7a8d-ef57-4253-96ed-e457e0062eb5 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram | CITALOPRAM | A-S Medication Solutions | 04ac5286-fc2e-4990-a574-ea21131ef731 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | 283672 |
| Citalopram | CITALOPRAM HYDROBROMIDE | A-S Medication Solutions | fc766b76-18c1-42cd-b276-f720f5821c11 | 2024-04-25 | Boxed warning, Warnings, Adverse reactions | 200371 |
| Citalopram | CITALOPRAM HYDROBROMIDE | A-S Medication Solutions | c6730edc-7226-4521-a04a-1bf296b01b8d | 2024-02-13 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram | CITALOPRAM | NuCare Pharmaceuticals,Inc. | 0dfb11d9-f48d-56ee-e063-6294a90ad256 | 2024-01-02 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | A-S Medication Solutions | 9059c8f1-8755-492d-aba2-5f5088ce69d3 | 2023-12-26 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | A-S Medication Solutions | 9d2f8f9f-9710-48e0-bc18-105a2af1073b | 2023-12-04 | Boxed warning, Warnings, Adverse reactions | 200371 |
| Celexa | CITALOPRAM | Allergan, Inc. | 4259d9b1-de34-43a4-85a8-41dd214e9177 | 2023-10-09 | Boxed warning, Warnings, Adverse reactions | 283672 200371 309314 |
| Citalopram | CITALOPRAM HYDROBROMIDE | NCS HealthCare of KY, LLC dba Vangard Labs | fd761647-e16b-45b3-a4bc-364de0ed7015 | 2023-09-07 | Boxed warning, Warnings, Adverse reactions | 283672 200371 309314 |
| Citalopram Hydrobromide | CITALOPRAM HYDROBROMIDE | Proficient Rx LP | 4eb71151-241a-476e-a495-4a021bc55bda | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Proficient Rx LP | f37cc307-8b7d-4e5c-8beb-cd8779bc86a7 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7 | 2020-05-13 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Aphena Pharma Solutions - Tennessee, LLC | 31ddd184-7560-473c-b674-5fa3187c5598 | 2020-04-24 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 0867140e-a483-4bf7-8326-4a9730cc9d9d | 2020-04-22 | Boxed warning, Warnings, Adverse reactions | 309314 |
| Citalopram | CITALOPRAM HYDROBROMIDE | Proficient Rx LP | 289c1d5e-902f-47db-85b8-5e1a55ec8684 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 200371 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.